NetEase Downbeat Q3 Results, Joins Red Robin, Sellas Life Sciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures rose, but NetEase slid 5.2% after missing Q3 earnings and sales estimates; Red Robin and Sellas also fell sharply premarket.


